Celecoxib and Halaven drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Celecoxib (celecoxib) and Halaven (eribulin mesylate). Common drug interactions include neutropenia among females.

The phase IV clinical study analyzes what interactions people have when they take Celecoxib and Halaven. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Celecoxib?

Celecoxib has active ingredients of celecoxib. It is often used in arthritis. eHealthMe is studying from 38,217 Celecoxib users. Check the latest studies of Celecoxib.

What is Halaven?

Halaven has active ingredients of eribulin mesylate. eHealthMe is studying from 3,881 Halaven users. Check the latest studies of Halaven.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

13 people who take Celecoxib and Halaven together, and have interactions are studied.

Celecoxib and Halaven drug interactions.

What are the common drug interactions of Celecoxib and Halaven, by gender? *:

female:

Neutropenia (an abnormally low number of neutrophils)
Interstitial lung disease
Anxiety
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Obstructive airways disorder (a progressive disease that makes it hard to breathe)
Pneumonia bacterial (pneumonia associated with bacterial infection)
Leukopenia (less number of white blood cells in blood)
Thrombocytopenia (decrease of platelets in blood)
Pyrexia (fever)
Depressed level of consciousness

male:

n/a

What are the common drug interactions of Celecoxib and Halaven, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Thrombocytopenia (decrease of platelets in blood)
Neutropenia (an abnormally low number of neutrophils)
Depressed level of consciousness
Pyrexia (fever)
Nausea (feeling of having an urge to vomit)
Pneumocystis jiroveci pneumonia (fungal infection of the lungs)
Obstructive airways disorder (a progressive disease that makes it hard to breathe)
Interstitial lung disease
Leukopenia (less number of white blood cells in blood)

60+:

Pulmonary haemorrhage (acute bleeding from the lung)
Neutropenia (an abnormally low number of neutrophils)
Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
Anxiety
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Pyrexia (fever)
Interstitial lung disease
Pneumonia bacterial (pneumonia associated with bacterial infection)

What are the existing conditions these people have? *

Metastases To Lymph Nodes (cancer spreads to lymph node): 5 people, 38.46%
Metastases To Lung (cancer spreads to lung): 5 people, 38.46%
Breast Cancer: 5 people, 38.46%
Pain: 4 people, 30.77%
Metastases To Liver (cancer spreads to liver): 4 people, 30.77%
Metastases To Bone (cancer spreads to bone): 3 people, 23.08%
Breast Cancer Recurrent: 3 people, 23.08%
Breast Cancer Metastatic: 3 people, 23.08%
Oedema (fluid collection in tissue): 2 people, 15.38%
Metastases To Peritoneum (cancer spreads to peritoneum): 2 people, 15.38%

* Approximation only. Some reports may have incomplete information.

Do you take Celecoxib and Halaven?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously